Market Executive Summary

The global market for Internal Neuromodulation was estimated to be worth US$ 2438 million in 2024 and is forecast to a readjusted size of US$ 4044 million by 2031 with a CAGR of 7.6% during the forecast period 2025-2031.

Neuromodulation is used to regulate functions of nervous system, such as therapeutic alteration, inhibition, stimulation, modification, and others. There are two types of neuromodulation external neuromodulation and internal neuromodulation. Internal neuromodulation block or repair neuron signals of pain from reaching the brain using electrical impulses. These devices reduce highest levels of pain for various chronic or refractory diseases. Its clinical significance in pain reduction and therapeutics has lead a wide acceptance in the North American region.

The driving factors of the internal neuromodulation market are rising prevalence of neurological disorders, increase in the aging population, strong product pipeline, expanded target applications and new indications, and investments and funds. Moreover, technological advancements present opportunities for growth of the market.

This report aims to provide a comprehensive presentation of the global market for Internal Neuromodulation, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Internal Neuromodulation by region & country, by Type, and by Application.

The Internal Neuromodulation market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Internal Neuromodulation.

Global Internal Neuromodulation Companies Covered

Medtronic PLC, Abbott, Boston Scientific Corp., Cerbomed GMBH, Cyberonics, Biocontrol Medical, Depuy Synthes Companies, Enteromedics, Synapse Biomedical, Uroplasty, Greatbatch, Abbott Laboratories, Nevro Corporation, NeuroSigma, MicroTransponder, Neuronetics, LivaNova PLC, Bioventus Inc, NeuroPace Inc

Global Internal Neuromodulation Market, by Region

North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Internal Neuromodulation Market, Segment by Type

Spinal Cord Stimulator

Deep Brain Stimulator

Sacral Nerve Stimulator

Vagus Nerve Stimulator

Gastric Neuro Stimulator

Global Internal Neuromodulation Market, Segment by Application

Parkinsons Disease

Chronic Pain

Others

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Internal Neuromodulation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Internal Neuromodulation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Internal Neuromodulation in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Related Reports:

Global Minimally Invasive Neurosurgical System Market Size, Share, Competitive Analysis, Key Players, Growth Drivers, Trends, Opportunities, Revenue Analysis, and Demand Forecast to 2032

Global Neuroprosthetics Market Research Report 2022 Professional Edition